Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Por Megwalu, Ifeanyichukwu I., Vlahiotis, Anna, Radwan, Mohamed, Piccirillo, Jay F., Kibel, Adam S.
Publicado em 2007

Risk of Urinary Incontinence Following Prostatectomy: The Role of Physical Activity and Obesity

Por Wolin, Kathleen Y., Luly, Jason, Sutcliffe, Siobhan, Andriole, Gerald L., Kibel, Adam S.
Publicado em 2009

Ureteral Injury in Laparoscopic Gynecologic Surgery

Por Manoucheri, Elmira, Cohen, Sarah L, Sandberg, Evelien M, Kibel, Adam S, Einarsson, Jon
Publicado em 2012

Early Oncologic Outcomes of Robotic versus Open Radical Cystectomy for Urothelial Cancer

Por Nepple, Kenneth G., Strope, Seth A., 3rd, Robert L. Grubb, Kibel, Adam S.
Publicado em 2011

Constitutive β-catenin Activation Induces Male-Specific Tumorigenesis in the Bladder Urothelium

Por Lin, Congxing, Yin, Yan, Stemler, Kristina, Humphrey, Peter, Kibel, Adam S., Mysorekar, Indira U., Ma, Liang
Publicado em 2013

PREDICTING RISK OF BLADDER CANCER USING CLINICAL AND DEMOGRAPHIC INFORMATION FROM PROSTATE, LUNG, COLORECTAL, AND OVARIAN CANCER (PLCO) SCREENING TRIAL PARTICIPANTS

Por Mir, Maria C., Stephenson, Andrew J., Grubb, Robert L., Black, Amanda, Kibel, Adam S., Izmirlian, Grant
Publicado em 2013

Who Should Be Included in a Clinical Trial of Screening for Bladder Cancer? A Decision Analysis of Data From the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Por Vickers, Andrew J., Bennette, Caroline, Kibel, Adam S., Black, Amanda, Izmirlian, Grant, Stephenson, Andrew J., Bochner, Bernard
Publicado em 2012

Randomized Controlled Trial of Oxybutynin Extended Release Versus Placebo for Urinary Symptoms During Intravesical Bacillus Calmette-Guérin Treatment

Por Johnson, Michael H., Nepple, Kenneth G., Peck, Vicky, Trinkaus, Kathryn, Klim, Aleksandra, Sandhu, Gurdarshan S., Kibel, Adam S.
Publicado em 2012

Calcium intake, polymorphisms of the calcium-sensing receptor, and recurrent/aggressive prostate cancer

Por Binder, Moritz, Shui, Irene M., Wilson, Kathryn M., Penney, Kathryn L., Mucci, Lorelei A., Kibel, Adam S.
Publicado no Cancer Causes Control (2015)

Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC)

Por Aizer, Ayal A., Urun, Yuksel, McKay, Rana R., Kibel, Adam S., Nguyen, Paul L., Choueiri, Toni K.
Publicado em 2014

A Guide for Clinicians in the Evaluation of Emerging Molecular Diagnostics for Newly Diagnosed Prostate Cancer

Por Canfield, Steven E, Kibel, Adam S, Kemeter, Michael J, Febbo, Phillip G, Lawrence, H. Jeffrey, Moul, Judd W
Publicado no Rev Urol (2014)

Treatment Decision Making in Patients with Bladder Cancer

Por Berry, Donna L., Nayak, Manan, Halpenny, Barbara, Harrington, Shannon, Loughlin, Kevin R., Chang, Peter, Rosenberg, Jonathan E., Kibel, Adam S.
Publicado no Bl Cancer (2015)

Magnetic Resonance Diffusion Characteristics of Histologically Defined Prostate Cancer in Humans

Por Xu, Junqian, Humphrey, Peter A., Kibel, Adam S., Snyder, Abraham Z., Narra, Vamsidhar R., Ackerman, Joseph J.H., Song, Sheng-Kwei
Publicado em 2009

Adjuvant Leuprolide With or Without Docetaxel in Patients With High-Risk Prostate Cancer After Radical Prostatectomy (TAX-3501): Important Lessons for Future Trials

Por Schweizer, Michael T., Huang, Peng, Kattan, Michael W., Kibel, Adam S., de Wit, Ronald, Sternberg, Cora N., Epstein, Jonathan I., Eisenberger, Mario A.
Publicado em 2013

THE IMPACT OF COMORBIDITY ON OVERALL SURVIVAL IN PATIENTS SURGICALLY TREATED FOR RENAL CELL CARCINOMA

Por Berger, David A., Megwalu, Ifeanyichukwu I., Vlahiotis, Anna, Radwan, Mohamed H., Serrano, Maria F., Humphrey, Peter A., Piccirillo, Jay F., Kibel, Adam S.
Publicado em 2008

Prospective Study of [(18)F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Muscle-Invasive Bladder Carcinoma

Por Kibel, Adam S., Dehdashti, Farrokh, Katz, Matthew D., Klim, Aleksandra P., Grubb, Robert L., Humphrey, Peter A., Siegel, Cary, Cao, Dengfeng, Gao, Feng, Siegel, Barry A.
Publicado em 2009

Association of CASP8 D302H Polymorphism with Reduced Risk of Aggressive Prostate Carcinoma

Por Lubahn, Jessica, Berndt, Sonja I., Jin, Carol H., Klim, Aleksandra, Luly, Jason, Wu, William S., Isaacs, Sarah, Wiley, Kathleen, Isaacs, William B., Suarez, Brian K., Hayes, Richard B., Kibel, Adam S.
Publicado em 2010

(11)C-Acetate PET/CT before Radical Prostatectomy: Nodal Staging and Treatment Failure Prediction

Por Haseebuddin, Mohammed, Dehdashti, Farrokh, Siegel, Barry A., Liu, Jingxia, Roth, Elizabeth B., Nepple, Kenneth G., Siegel, Cary L., Fischer, Keith C., Kibel, Adam S., Andriole, Gerald L., Miller, Tom R.
Publicado em 2013

Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database

Por Gandaglia, Giorgio, Varda, Briony, Sood, Akshay, Pucheril, Daniel, Konijeti, Ramdev, Sammon, Jesse D., Sukumar, Shyam, Menon, Mani, Sun, Maxine, Chang, Steven L., Montorsi, Francesco, Kibel, Adam S., Trinh, Quoc-Dien
Publicado em 2014

SnoRNA U50 is a candidate tumor suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer

Por Dong, Xue-Yuan, Rodriguez, Carmen, Guo, Peng, Sun, Xiaodong, Talbot, Jeffrey T., Zhou, Wei, Petros, John, Li, Qunna, Vessella, Robert L., Kibel, Adam S., Stevens, Victoria L., Calle, Eugenia E., Dong, Jin-Tang
Publicado em 2008